Murine resistance to type III group B streptococci

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Type III group B streptococci (GBS) pose a significant threat, necessitating a deeper understanding of host defense mechanisms.
• The roles of serum, complement, and the reticuloendothelial system in combating GBS infections are not fully elucidated.

Purpose of the Study:

• To investigate the contribution of serum, complement, and macrophages to mouse resistance against type III GBS.
• To determine the specific immune components critical for surviving GBS infection via different inoculation routes.

Main Methods:

• Mice were subjected to complement depletion using cobra venom factor.
• Mice were treated with oleic acid to impair macrophage function, administered via intraperitoneal (IP) or intravenous (IV) routes.
• Chick embryos were used to assess the protective capacity of normal mouse serum against GBS.

Main Results:

• Normal mouse serum did not protect chick embryos from lethal GBS inoculation.
• Complement-depleted mice retained resistance to IP GBS infection.
• Mice with impaired peritoneal macrophages (IP oleic acid) became susceptible to GBS, while IV oleic acid treatment did not abrogate resistance.

Conclusions:

• Peritoneal macrophages are essential for effective murine defense against intraperitoneal type III GBS infection.
• Complement and normal serum do not appear to be primary protective factors against this specific GBS challenge.
• The route of immune modulation (IP vs. IV oleic acid) significantly impacts the outcome of GBS infection, highlighting the localized role of macrophages.